CCL2 and retinal ischemia: Furthermore, as revealed by the in vitro analysis and in vivo studies, SAC might protect against retinal ischemia by acting as an anti-oxidant and inhibiting the upregulation of upstream biomarkers MCP-1 and PKM2, as presently demonstrated in RPE cells subjected to 500 μM H2O2-induced oxidative stress.